Shares of Addus HomeCare Corporation (NASDAQ:ADUS – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the eleven ratings firms that are presently covering the company, Marketbeat reports. One analyst has rated the stock with a sell rating, four have assigned a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company. The average 12 month price target among brokerages that have updated their coverage on the stock in the last year is $128.00.
A number of equities research analysts have weighed in on ADUS shares. Royal Bank Of Canada lifted their price objective on Addus HomeCare from $130.00 to $134.00 and gave the company an “outperform” rating in a report on Wednesday, August 5th. Raymond James Financial set a $125.00 target price on Addus HomeCare in a research note on Monday. Bank of America reissued a “neutral” rating and issued a $125.00 price target (down from $140.00) on shares of Addus HomeCare in a report on Monday. Weiss Ratings upgraded Addus HomeCare from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, July 9th. Finally, Citigroup downgraded Addus HomeCare from a “market outperform” rating to a “neutral” rating in a research note on Monday.
Get Our Latest Analysis on Addus HomeCare
Insider Buying and Selling
Hedge Funds Weigh In On Addus HomeCare
Institutional investors and hedge funds have recently made changes to their positions in the stock. Tidal Investments LLC purchased a new position in shares of Addus HomeCare in the 2nd quarter valued at about $664,000. Integrated Wealth Concepts LLC boosted its holdings in Addus HomeCare by 22.4% during the second quarter. Integrated Wealth Concepts LLC now owns 2,965 shares of the company’s stock worth $298,000 after buying an additional 542 shares in the last quarter. Squarepoint Ops LLC boosted its holdings in Addus HomeCare by 40.4% during the second quarter. Squarepoint Ops LLC now owns 21,219 shares of the company’s stock worth $2,132,000 after buying an additional 6,102 shares in the last quarter. Nykredit A S acquired a new position in Addus HomeCare during the second quarter worth about $110,000. Finally, Amundi grew its position in Addus HomeCare by 37.9% during the second quarter. Amundi now owns 3,955 shares of the company’s stock worth $397,000 after buying an additional 1,087 shares during the period. 95.35% of the stock is owned by institutional investors and hedge funds.
Addus HomeCare Stock Down 0.4%
Shares of Addus HomeCare stock opened at $118.06 on Friday. Addus HomeCare has a one year low of $87.95 and a one year high of $124.43. The company has a market cap of $2.20 billion, a P/E ratio of 20.71, a PEG ratio of 1.69 and a beta of 0.86. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.69 and a current ratio of 1.69. The firm has a fifty day moving average of $116.49 and a two-hundred day moving average of $103.60.
Addus HomeCare (NASDAQ:ADUS – Get Free Report) last issued its earnings results on Monday, August 3rd. The company reported $1.73 earnings per share for the quarter, beating the consensus estimate of $1.70 by $0.03. Addus HomeCare had a net margin of 7.13% and a return on equity of 9.96%. The business had revenue of $377.41 million for the quarter, compared to the consensus estimate of $376.24 million. During the same quarter in the previous year, the firm earned $1.49 earnings per share. The business’s quarterly revenue was up 8.0% compared to the same quarter last year. On average, analysts forecast that Addus HomeCare will post 6.3 earnings per share for the current year.
About Addus HomeCare
Addus HomeCare Corporation provides home-based care services to older adults, people with disabilities and individuals with chronic or complex medical needs. The company operates through three primary service lines: personal care, hospice and home health.
Its personal care services include assistance with daily living activities, such as bathing, dressing, meal preparation and household tasks. Addus also provides hospice care for individuals with terminal illnesses, as well as home health services that may include skilled nursing, therapy and other clinical support.
See Also
- Five stocks we like better than Addus HomeCare
- Aeluma’s Selloff Could Be Setting Up Its Next Big Move
- Crypto Bill Stalls, Smart Money Calls: Time to Buy the Dip?
- The September Scramble: Find Sanctuary in These 3 Defensive Dividend Stocks
- The Fed’s Rate Hike Could Backfire If Oil Prices Collapse
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.
